Any current/future new fundraising through debt or equity?

Currently, Astral Limited does not plan any big fundraising through debt or equity. Company intends to keep cash on hand and may consider positive opportunities if they arise. Future cash utilization plans will depend on next year's budget and market conditions. If no utilization plan is decided, surplus cash may be returned to shareholders. CAPEX for FY25 is expected around Rs. 450 crore; for FY26, around Rs. 250 crore. Most plants are completed; no major new facility additions planned. Capacity expansions are mostly through phased additions in existing plants, e.g., Kanpur capacity expansion

Any current/future capex/capital investment/strategic investment?

FY25 CAPEX is expected to be around Rs. 450 crore. FY26 CAPEX is planned to reduce significantly to around Rs. 250 crore. Most plants are already established; Kanpur plant nearing completion. No major new facility additions planned; focus is on capacity expansion within existing plants. Kanpur plant capacity addition of 60,000 MT is planned in two phases: 30,000 MT in FY26 and 30,000 MT in FY27. Hyderabad plant capacity already expanded by 25,000 MT in the current year, with possible further additions depending on utilization. Small machinery additions continue for existing operations. Technol

Future growth expectations in sales/revenue/volumes?

Historical topline growth has been around 15%; FY24 growth was 9% due to decline in polymer and chemical prices (Page 17). FY26 expected value growth of approximately 15%, with volume growth between 10%-12%, indicating recovery from prior price declines (Page 17). Volumes are expected to grow 10%-15% minimum next year, benefiting from a lower base this year; potential for >15% if economic conditions improve (Page 8). Plumbing volume growth for the current year subdued (~4.3% in 9 months), with uncertain Q4 outlook dependent on government spending and anti-dumping duty decisions; potential for

Future growth expectations in earnings/operating earnings/profits/EPS?

Astral expects topline growth to normalize back to around 15% annually, driven by volume growth of 10-15% and value growth potentially reaching 15% or higher as polymer and chemical prices stabilize. (Page 17-18) EBITDA margin aspiration remains stable at 15.5%-16% overall, with adhesives India operations targeting 14%-16% margins and maintaining similar strong margin levels going forward. (Pages 5 and 7) UK and US businesses are undergoing corrective measures; positive EBITDA improvement and margin benefits expected from Q1 FY26 onwards due to technology integration and cost rationalization

Astral LtdQ4 FY25Industrial Products

Astral Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,592P/E: 72.5Market Cap: ₹38.5K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Historical topline growth has been around 15%; FY24 growth was 9% due to decline in polymer and chemical prices (Page 17).
→FY26 expected value growth of approximately 15%, with volume growth between 10%-12%, indicating recovery from prior price declines (Page 17).
→Volumes are expected to grow 10%-15% minimum next year, benefiting from a lower base this year; potential for >15% if economic conditions improve (Page 8).
→Plumbing volume growth for the current year subdued (~4.3% in 9 months), with uncertain Q4 outlook dependent on government spending and anti-dumping duty decisions; potential for double-digit growth if conditions align (Page 7).
→Growth in paint segment targeted at 15%-20% pace steadily, without aggressive market saturation or margin dilution (Page 20).
→Expansion in capacity (Kanpur plant adding 30,000 MT in FY26) supports volume growth (Page 13).
→Overall, management aims to return to consistent 15% topline growth aligning with gross market conditions (Page 17).

Margin guidance

Category 3

→Astral expects topline growth to normalize back to around 15% annually, driven by volume growth of 10-15% and value growth potentially reaching 15% or higher as polymer and chemical prices stabilize. (Page 17-18)
→EBITDA margin aspiration remains stable at 15.5%-16% overall, with adhesives India operations targeting 14%-16% margins and maintaining similar strong margin levels going forward. (Pages 5 and 7)
→UK and US businesses are undergoing corrective measures; positive EBITDA improvement and margin benefits expected from Q1 FY26 onwards due to technology integration and cost rationalization. (Page 4)
→Paint business is expected to grow steadily at a double-digit pace without aggressive cash burn, aiming at positive EBITDA in a few quarters. (Pages 20 and 22)
→CAPEX planned to reduce significantly from around Rs. 450 crore in FY25 to Rs. 250 crore in FY26, reflecting completion of major capacity expansions. (Page 11)
→Overall, Astral plans profitable volume-led growth with focus on quality and value-added products supporting margin stability. (Pages 5, 7, 17)

3 more insights locked — sign up free to unlock

Fundraise plans

→Currently, Astral Limited does not plan any big fundraising through debt or equity.
→Company intends to keep cash on hand and may consider positive opportunities if they arise.
→Future cash utilization plans will depend on next year's budget and market conditions.
→If no utilization plan is decided, surplus cash may be returned to shareholders.
→CAPEX for FY25 is expected around Rs. 450 crore; for FY26, around Rs. 250 crore.
→Most plants are completed; no major new facility additions planned.
→Capacity expansions are mostly through phased additions in existing plants, e.g., Kanpur capacity expansion.
→No indication of immediate debt or equity fundraising from the management.

Order book

The transcript provided from the Astral Limited document does not explicitly mention details on the current or expected order book or pending orders. However, insights from the discussion related to business segments and growth include: - Positive response and balanced business growth in institutional and retail segments (bathware and piping). - Growing presence pan India with good acceptance and demand in real estate and retail. - Exports are growing with positive orders, including value-added products, although exact numbers are undisclosed. - Anticipated volume growth of 10% to 15% driven by market recovery, budget impacts, and expected anti-dumping duties. - Capacity expansions underway, including 60,000 MT at Kanpur plant and incremental additions at Hyderabad. - Cautious outlook due to external factors like government spending, liquidity, and anti-dumping duty announcements affecting order momentum. No explicit quantitative data on orderbook/pending orders is disclosed in the available transcript.

Capex plans

Yes

→FY25 CAPEX is expected to be around Rs. 450 crore.
→FY26 CAPEX is planned to reduce significantly to around Rs. 250 crore.
→Most plants are already established; Kanpur plant nearing completion.
→No major new facility additions planned; focus is on capacity expansion within existing plants.
→Kanpur plant capacity addition of 60,000 MT is planned in two phases: 30,000 MT in FY26 and 30,000 MT in FY27.
→Hyderabad plant capacity already expanded by 25,000 MT in the current year, with possible further additions depending on utilization.
→Small machinery additions continue for existing operations.
→Technology acquisition from Europe signed to aid margin improvement, expected to be operational in Q1 (fiscal year not specified).
→No large CAPEX planned for faucets or adhesives; minor asset purchase of Rs. 23 crore in faucets.

How does Astral Ltd rank vs peers in Industrial Products?

Pro feature

1Astral Ltd

Rev 3Mar 3

See full Industrial Products sector rankings

Want more stocks like Astral Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio